ENDONOVO THERAPEUTICS, INC. (ENDV) is a publicly traded company in the Unknown sector. Across all available filings, 2 corporate insiders have executed 1000 transactions totaling $55.9K, demonstrating a bullish sentiment with $55.9K in net insider flow. The most recent transaction on Jul 1, 2020 involved a purchase of 100 shares valued at $10.
No significant insider buying has been recorded for ENDV in the recent period.
No significant insider selling has been recorded for ENDV in the recent period.
Based on recent SEC filings, insider sentiment for ENDV is bullish with an Insider Alignment Score of 100/100 and a net flow of $55.9K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at ENDONOVO THERAPEUTICS, INC. (ENDV) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 2 insiders are actively trading ENDV stock, having executed 1000 transactions in the past 90 days. The most active insider is Alan Brian Collier (Executive), who has made 776 transactions totaling $45.0K.
Get notified when executives and directors at ENDV file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 1, 2020 | Brian Collier Alan | Executive | Purchase | 100 | $0.10 | $10 | |
| Jul 1, 2020 | Brian Collier Alan | Executive | Purchase | 100 | $0.10 | $10 | |
| Jun 30, 2020 | Brian Collier Alan | Executive | Purchase | 200 | $0.10 | $20 | |
| Feb 22, 2020 | Brian Collier Alan | Executive | Purchase | 100 | $0.96 | $96 | |
| Jan 2, 2020 | Brian Collier Alan | Executive | Purchase | 100 | $1.75 | $175 | |
| Jan 2, 2020 | Brian Collier Alan | Executive | Purchase | 100 | $1.75 | $175 | |
| Dec 30, 2019 | Brian Collier Alan | Executive | Purchase | 100 | $2.25 | $225 | |
| Dec 30, 2019 | Brian Collier Alan | Executive | Purchase | 100 | $2.25 | $225 | |
| Dec 20, 2019 | Brian Collier Alan | Executive | Purchase | 100 | $1.50 | $150 | |
| Dec 20, 2019 | Brian Collier Alan | Executive | Purchase | 100 | $N/A | $0 | |
| Dec 16, 2019 | Brian Collier Alan | Executive | Purchase | 500 | $N/A | $0 | |
| Dec 16, 2019 | Brian Collier Alan | Executive | Purchase | 500 | $N/A | $0 | |
| Dec 12, 2019 | Brian Collier Alan | Executive | Purchase | 1,000 | $N/A | $0 | |
| Dec 12, 2019 | Brian Collier Alan | Executive | Purchase | 1,000 | $N/A | $0 | |
| Dec 11, 2019 | Brian Collier Alan | Executive | Purchase | 100 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 1000 | $55.9K | 100.0% |
Insiders at ENDONOVO THERAPEUTICS, INC. are accumulating shares at an accelerated pace. With 2 insiders making 1000 transactions totaling $55.9K in purchases versus $0 in sales, the net buying activity of $55.9K signals strong executive confidence. Alan Brian Collier (Executive) leads the buying activity with $45.0K in transactions across all time.